Premium
Small‐Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α
Author(s) -
Buckley Dennis L.,
Gustafson Jeffrey L.,
Van Molle Inge,
Roth Anke G.,
Tae Hyun Seop,
Gareiss Peter C.,
Jorgensen William L.,
Ciulli Alessio,
Crews Craig M.
Publication year - 2012
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.201206231
Subject(s) - dna ligase , small molecule , ubiquitin ligase , computational biology , computer science , ic50 , transcription (linguistics) , chemistry , biochemistry , information retrieval , bioinformatics , biology , enzyme , gene , in vitro , ubiquitin , philosophy , linguistics
By design : Novel small‐molecule inhibitors of the interaction between the von Hippel–Lindau ligase (VHL) and its molecular target HIF1α, a transcription factor involved in oxygen sensing, have been developed and studied. The most potent inhibitor binds with an IC 50 value of 0.9 μ M and is thus the first sub‐micromolar inhibitor of the VHL–HIF1α interaction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom